In addition, the injection of a plasmid containing human IL-37 improved the skin lesions with reduced IFN-γ expression in a mouse model of psoriasis in which epidermis-specific VEGF-A was overexpressed [80]. This evidence concerns the gene IL37 and psoriasis.